Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 519

Showing 26-50 of 519 citing articles:

Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
Miguel López de Rodas, María Villalba, Miguel F. Sanmamed, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 3
Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction
Kinga Bernatowicz, Ramon Amat, Olivia Prior, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 1, pp. e009140-e009140
Open Access | Times Cited: 2
Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death
Lvqin Fu, Xianbin Ma, Yuan‐Tong Liu, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 4, pp. 1718-1728
Closed Access | Times Cited: 59
How to improve photodynamic therapy-induced antitumor immunity for cancer treatment?
Min Zhang, Yifan Zhao, He Ma, et al.
Theranostics (2022) Vol. 12, Iss. 10, pp. 4629-4655
Open Access | Times Cited: 57
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Zhi Zhu, A. J. Robert McGray, Weijian Jiang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 57
New Advances in Biomedical Application of Polymeric Micelles
Ana Figueiras, Cátia Domingues, Ivana Jarak, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1700-1700
Open Access | Times Cited: 54
Mechanisms of tumor resistance to immune checkpoint blockade and combination strategies to overcome resistance
Xiaoting Zhou, Yanghong Ni, Xiao Liang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 52
STING as an emerging therapeutic target for drug discovery: Perspectives from the global patent landscape
Xiangjun Kong, Hua‐Li Zuo, Hsien‐Da Huang, et al.
Journal of Advanced Research (2022) Vol. 44, pp. 119-133
Open Access | Times Cited: 45
Cancer immunotherapy by immune checkpoint blockade and its advanced application using bio-nanomaterials
Dhananjay Yadav, Minseok Kwak, Pallavi Chauhan, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 909-922
Closed Access | Times Cited: 43
High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis
Sun-Young Jung, You Jeong Heo, Sehhoon Park
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e006454-e006454
Open Access | Times Cited: 40
Ionizing Radiation Triggers the Antitumor Immunity by Inducing Gasdermin E-Mediated Pyroptosis in Tumor Cells
Wei Cao, Guodong Chen, Lijun Wu, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 115, Iss. 2, pp. 440-452
Closed Access | Times Cited: 39
Current clinical landscape of oncolytic viruses as novel cancer immunotherapeutic and recent preclinical advancements
Chae‐Ok Yun, JinWoo Hong, A‐Rum Yoon
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Polarization of Tumor-Associated Macrophages Promoted by Vitamin C-Loaded Liposomes for Cancer Immunotherapy
Zhaoyu Ma, Mingkun Yang, Mohamed F. Foda, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 17389-17401
Closed Access | Times Cited: 38
Next generation radiotheranostics promoting precision medicine
Kelsey L. Pomykala, Boris Hadaschik, Oliver Sartor, et al.
Annals of Oncology (2023) Vol. 34, Iss. 6, pp. 507-519
Open Access | Times Cited: 36
Spleen-Targeted mRNA Delivery by Amphiphilic Carbon Dots for Tumor Immunotherapy
Ping Chen, Xi He, Yue Hu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 16, pp. 19937-19950
Closed Access | Times Cited: 36
Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy
Yue Wang, Shikun Zhou, Yan Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Drug-loaded microbubble delivery system to enhance PD-L1 blockade immunotherapy with remodeling immune microenvironment
Jun Zheng, Ju Huang, Liang Zhang, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 29
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
Niki Gavrielatou, E. Fortis, Aris Spathis, et al.
Annals of Oncology (2023) Vol. 35, Iss. 4, pp. 340-350
Open Access | Times Cited: 26
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
Lingling Zhu, Xianzhe Yu, Ting Cao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 6, pp. 2464-2482
Open Access | Times Cited: 23
CircRNAs in tumor immunity and immunotherapy: Perspectives from innate and adaptive immunity
Lulu Yu, Qi Xiao, Bing Yu, et al.
Cancer Letters (2023) Vol. 564, pp. 216219-216219
Open Access | Times Cited: 22
ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade
Xiao‐Lan Liu, Xufeng Cen, Ronghai Wu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy
Renhong Huang, Zheng Wang, Jin Hong, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 10
Open Access | Times Cited: 22
Nanoparticle-based immunoengineering strategies for enhancing cancer immunotherapy
Bao-Toan Nguyen Dang, Taeg Kyu Kwon, Sooyeun Lee, et al.
Journal of Controlled Release (2023) Vol. 365, pp. 773-800
Closed Access | Times Cited: 22
Combination therapy with oncolytic virus and T cells or mRNA vaccine amplifies antitumor effects
Rao Fu, Ruoyao Qi, Hualong Xiong, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma
Mara John, Moutaz Helal, Johannes Duell, et al.
Blood (2024) Vol. 144, Iss. 20, pp. 2121-2135
Closed Access | Times Cited: 14

Scroll to top